WINTER SPRINGS, Fla., Oct. 26, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced FDA 510(k) clearance of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient vital ...
The scheduled release of the 2025 first quarter financial results indicates transparency and a commitment to keeping stakeholders informed about the company's performance. The upcoming conference call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback